Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuyang Chen

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
International Immunopharmacology|July 9, 2023
Proteomics profiling of CD4 + T-cell-derived exosomes from patients with rheumatoid arthritisLixin Huang, Ling Liang, Zhuyi Ji, et al.
Cancer Management and Research|August 3, 2019
Stanniocalcin 2 (STC2) expression promotes post-radiation survival, migration and invasion of nasopharyngeal carcinoma cellsHuocong He, Shuo Qie, Qiaojuan Guo, et al.
Nature Communications|April 29, 2016
Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2Neil Justin, Ying Zhang, Cataldo Tarricone, et al.
Nature Communications|February 22, 2019
Targeting MC1R depalmitoylation to prevent melanomagenesis in redheadsShuyang Chen, Changpeng Han, Xiao Miao, et al.
Nature|September 5, 2017
Palmitoylation-dependent activation of MC1R prevents melanomagenesisShuyang Chen, Bo Zhu, Chengqian Yin, et al.
Oncogene|May 23, 2018
Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapyBo Zhu, Liming Tang, Shuyang Chen, et al.
Journal of Hepatology|September 1, 2022
IL-6/STAT3 axis dictates the PNPLA3-mediated susceptibility to non-alcoholic fatty liver diseaseJiwoon Park, Yuanyuan Zhao, Fan Zhang, et al.
Journal for Immunotherapy of Cancer|December 10, 2020
A20 regulates the therapeutic effect of anti-PD-1 immunotherapy in melanomaWeinan Guo, Jinyuan Ma, Sen Guo, et al.
Hepatology (Baltimore, Md.)|September 12, 2025
IL1β signaling mediates the interaction between hepatitis B and C virusesFan Zhang, Yuanyuan Zhao, Lu Bian, et al.
Cell|February 5, 2019
Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven MelanomagenesisChengqian Yin, Bo Zhu, Ting Zhang, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
International Immunopharmacology|July 9, 2023
Proteomics profiling of CD4 + T-cell-derived exosomes from patients with rheumatoid arthritisLixin Huang, Ling Liang, Zhuyi Ji, et al.
Cancer Management and Research|August 3, 2019
Stanniocalcin 2 (STC2) expression promotes post-radiation survival, migration and invasion of nasopharyngeal carcinoma cellsHuocong He, Shuo Qie, Qiaojuan Guo, et al.
Nature Communications|April 29, 2016
Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2Neil Justin, Ying Zhang, Cataldo Tarricone, et al.
Nature Communications|February 22, 2019
Targeting MC1R depalmitoylation to prevent melanomagenesis in redheadsShuyang Chen, Changpeng Han, Xiao Miao, et al.
Nature|September 5, 2017
Palmitoylation-dependent activation of MC1R prevents melanomagenesisShuyang Chen, Bo Zhu, Chengqian Yin, et al.
Oncogene|May 23, 2018
Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapyBo Zhu, Liming Tang, Shuyang Chen, et al.
Journal of Hepatology|September 1, 2022
IL-6/STAT3 axis dictates the PNPLA3-mediated susceptibility to non-alcoholic fatty liver diseaseJiwoon Park, Yuanyuan Zhao, Fan Zhang, et al.
Journal for Immunotherapy of Cancer|December 10, 2020
A20 regulates the therapeutic effect of anti-PD-1 immunotherapy in melanomaWeinan Guo, Jinyuan Ma, Sen Guo, et al.
Hepatology (Baltimore, Md.)|September 12, 2025
IL1β signaling mediates the interaction between hepatitis B and C virusesFan Zhang, Yuanyuan Zhao, Lu Bian, et al.
Cell|February 5, 2019
Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven MelanomagenesisChengqian Yin, Bo Zhu, Ting Zhang, et al.
Pageof 10